nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—CYP2D6—Hydroxyurea—head and neck cancer	0.329	0.449	CbGbCtD
Cyclobenzaprine—CYP1A2—Fluorouracil—head and neck cancer	0.153	0.208	CbGbCtD
Cyclobenzaprine—CYP2D6—Vinblastine—head and neck cancer	0.117	0.159	CbGbCtD
Cyclobenzaprine—CYP3A4—Vinblastine—head and neck cancer	0.0741	0.101	CbGbCtD
Cyclobenzaprine—CYP3A4—Docetaxel—head and neck cancer	0.0611	0.0832	CbGbCtD
Cyclobenzaprine—Ileus paralytic—Vinblastine—head and neck cancer	0.0109	0.041	CcSEcCtD
Cyclobenzaprine—Inappropriate antidiuretic hormone secretion—Vinblastine—head and neck cancer	0.00812	0.0305	CcSEcCtD
Cyclobenzaprine—Bone marrow depression—Hydroxyurea—head and neck cancer	0.00637	0.0239	CcSEcCtD
Cyclobenzaprine—Numbness—Vinblastine—head and neck cancer	0.00569	0.0214	CcSEcCtD
Cyclobenzaprine—Sensory loss—Vinblastine—head and neck cancer	0.00545	0.0205	CcSEcCtD
Cyclobenzaprine—Numbness—Fluorouracil—head and neck cancer	0.00374	0.014	CcSEcCtD
Cyclobenzaprine—Sensory loss—Fluorouracil—head and neck cancer	0.00357	0.0134	CcSEcCtD
Cyclobenzaprine—Cerebrovascular accident—Vinblastine—head and neck cancer	0.00349	0.0131	CcSEcCtD
Cyclobenzaprine—Disorientation—Hydroxyurea—head and neck cancer	0.00349	0.0131	CcSEcCtD
Cyclobenzaprine—Dysarthria—Fluorouracil—head and neck cancer	0.00327	0.0123	CcSEcCtD
Cyclobenzaprine—Face oedema—Hydroxyurea—head and neck cancer	0.00302	0.0113	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Vinblastine—head and neck cancer	0.00281	0.0106	CcSEcCtD
Cyclobenzaprine—Ageusia—Docetaxel—head and neck cancer	0.00276	0.0104	CcSEcCtD
Cyclobenzaprine—Euphoric mood—Fluorouracil—head and neck cancer	0.00266	0.01	CcSEcCtD
Cyclobenzaprine—Acute coronary syndrome—Vinblastine—head and neck cancer	0.0026	0.00978	CcSEcCtD
Cyclobenzaprine—Myocardial infarction—Vinblastine—head and neck cancer	0.00259	0.00972	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00259	0.00972	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Hydroxyurea—head and neck cancer	0.00256	0.00963	CcSEcCtD
Cyclobenzaprine—Disorientation—Fluorouracil—head and neck cancer	0.00251	0.00944	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Vinblastine—head and neck cancer	0.00246	0.00925	CcSEcCtD
Cyclobenzaprine—Weight increased—Hydroxyurea—head and neck cancer	0.00246	0.00923	CcSEcCtD
Cyclobenzaprine—Drowsiness—Hydroxyurea—head and neck cancer	0.00241	0.00904	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.00236	0.00886	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Vinblastine—head and neck cancer	0.00236	0.00886	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Vinblastine—head and neck cancer	0.00235	0.00884	CcSEcCtD
Cyclobenzaprine—Stomatitis—Hydroxyurea—head and neck cancer	0.00235	0.00882	CcSEcCtD
Cyclobenzaprine—Osteoarthritis—Fluorouracil—head and neck cancer	0.00225	0.00845	CcSEcCtD
Cyclobenzaprine—Hallucination—Hydroxyurea—head and neck cancer	0.00215	0.00808	CcSEcCtD
Cyclobenzaprine—Irritability—Fluorouracil—head and neck cancer	0.00215	0.00806	CcSEcCtD
Cyclobenzaprine—Ataxia—Fluorouracil—head and neck cancer	0.00211	0.00794	CcSEcCtD
Cyclobenzaprine—Alopecia—Vinblastine—head and neck cancer	0.00209	0.00787	CcSEcCtD
Cyclobenzaprine—Eosinophilia—Fluorouracil—head and neck cancer	0.00192	0.00723	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Vinblastine—head and neck cancer	0.00191	0.00719	CcSEcCtD
Cyclobenzaprine—Alopecia—Hydroxyurea—head and neck cancer	0.00191	0.00717	CcSEcCtD
Cyclobenzaprine—Malaise—Vinblastine—head and neck cancer	0.00186	0.00699	CcSEcCtD
Cyclobenzaprine—Vertigo—Vinblastine—head and neck cancer	0.00185	0.00696	CcSEcCtD
Cyclobenzaprine—Leukopenia—Vinblastine—head and neck cancer	0.00185	0.00694	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Fluorouracil—head and neck cancer	0.00185	0.00693	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00181	0.00679	CcSEcCtD
Cyclobenzaprine—Convulsion—Vinblastine—head and neck cancer	0.00179	0.00671	CcSEcCtD
Cyclobenzaprine—Hypertension—Vinblastine—head and neck cancer	0.00178	0.00669	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00175	0.00656	CcSEcCtD
Cyclobenzaprine—Discomfort—Vinblastine—head and neck cancer	0.00173	0.00652	CcSEcCtD
Cyclobenzaprine—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.00171	0.00642	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.0017	0.00638	CcSEcCtD
Cyclobenzaprine—Myocardial infarction—Fluorouracil—head and neck cancer	0.0017	0.00638	CcSEcCtD
Cyclobenzaprine—Malaise—Hydroxyurea—head and neck cancer	0.0017	0.00637	CcSEcCtD
Cyclobenzaprine—Stomatitis—Fluorouracil—head and neck cancer	0.00169	0.00635	CcSEcCtD
Cyclobenzaprine—Leukopenia—Hydroxyurea—head and neck cancer	0.00168	0.00633	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Vinblastine—head and neck cancer	0.00165	0.00619	CcSEcCtD
Cyclobenzaprine—Convulsion—Hydroxyurea—head and neck cancer	0.00163	0.00612	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Fluorouracil—head and neck cancer	0.00162	0.00607	CcSEcCtD
Cyclobenzaprine—Anorexia—Vinblastine—head and neck cancer	0.0016	0.00603	CcSEcCtD
Cyclobenzaprine—Discomfort—Hydroxyurea—head and neck cancer	0.00158	0.00594	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.00155	0.00581	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Fluorouracil—head and neck cancer	0.00154	0.0058	CcSEcCtD
Cyclobenzaprine—Oedema—Hydroxyurea—head and neck cancer	0.00154	0.00577	CcSEcCtD
Cyclobenzaprine—Ataxia—Docetaxel—head and neck cancer	0.00153	0.00573	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Vinblastine—head and neck cancer	0.00151	0.00568	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.0015	0.00565	CcSEcCtD
Cyclobenzaprine—Anorexia—Hydroxyurea—head and neck cancer	0.00146	0.0055	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Vinblastine—head and neck cancer	0.00146	0.0055	CcSEcCtD
Cyclobenzaprine—Constipation—Vinblastine—head and neck cancer	0.00144	0.00541	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Fluorouracil—head and neck cancer	0.00139	0.00522	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Vinblastine—head and neck cancer	0.00139	0.00521	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00138	0.00517	CcSEcCtD
Cyclobenzaprine—Alopecia—Fluorouracil—head and neck cancer	0.00137	0.00516	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Hydroxyurea—head and neck cancer	0.00137	0.00514	CcSEcCtD
Cyclobenzaprine—Somnolence—Hydroxyurea—head and neck cancer	0.00136	0.00513	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Hydroxyurea—head and neck cancer	0.00135	0.00508	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Hydroxyurea—head and neck cancer	0.00133	0.00501	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Docetaxel—head and neck cancer	0.00133	0.005	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Vinblastine—head and neck cancer	0.00133	0.005	CcSEcCtD
Cyclobenzaprine—Fatigue—Hydroxyurea—head and neck cancer	0.00132	0.00497	CcSEcCtD
Cyclobenzaprine—Constipation—Hydroxyurea—head and neck cancer	0.00131	0.00493	CcSEcCtD
Cyclobenzaprine—Weight increased—Docetaxel—head and neck cancer	0.00128	0.0048	CcSEcCtD
Cyclobenzaprine—Vision blurred—Fluorouracil—head and neck cancer	0.00128	0.00479	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00126	0.00475	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Vinblastine—head and neck cancer	0.00124	0.00466	CcSEcCtD
Cyclobenzaprine—Acute coronary syndrome—Docetaxel—head and neck cancer	0.00123	0.00463	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Docetaxel—head and neck cancer	0.00123	0.00461	CcSEcCtD
Cyclobenzaprine—Myocardial infarction—Docetaxel—head and neck cancer	0.00123	0.00461	CcSEcCtD
Cyclobenzaprine—Jaundice—Docetaxel—head and neck cancer	0.00122	0.00458	CcSEcCtD
Cyclobenzaprine—Stomatitis—Docetaxel—head and neck cancer	0.00122	0.00458	CcSEcCtD
Cyclobenzaprine—Leukopenia—Fluorouracil—head and neck cancer	0.00121	0.00455	CcSEcCtD
Cyclobenzaprine—Asthenia—Vinblastine—head and neck cancer	0.00121	0.00454	CcSEcCtD
Cyclobenzaprine—Convulsion—Fluorouracil—head and neck cancer	0.00117	0.00441	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Docetaxel—head and neck cancer	0.00117	0.00438	CcSEcCtD
Cyclobenzaprine—Myalgia—Fluorouracil—head and neck cancer	0.00115	0.00433	CcSEcCtD
Cyclobenzaprine—Chest pain—Fluorouracil—head and neck cancer	0.00115	0.00433	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Vinblastine—head and neck cancer	0.00115	0.00433	CcSEcCtD
Cyclobenzaprine—Discomfort—Fluorouracil—head and neck cancer	0.00114	0.00428	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00113	0.00425	CcSEcCtD
Cyclobenzaprine—Hepatitis—Docetaxel—head and neck cancer	0.00112	0.00422	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Docetaxel—head and neck cancer	0.00112	0.0042	CcSEcCtD
Cyclobenzaprine—Confusional state—Fluorouracil—head and neck cancer	0.00111	0.00419	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Docetaxel—head and neck cancer	0.00111	0.00419	CcSEcCtD
Cyclobenzaprine—Dizziness—Vinblastine—head and neck cancer	0.00111	0.00418	CcSEcCtD
Cyclobenzaprine—Oedema—Fluorouracil—head and neck cancer	0.0011	0.00415	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Fluorouracil—head and neck cancer	0.0011	0.00415	CcSEcCtD
Cyclobenzaprine—Asthenia—Hydroxyurea—head and neck cancer	0.0011	0.00414	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00108	0.00406	CcSEcCtD
Cyclobenzaprine—Tachycardia—Fluorouracil—head and neck cancer	0.00108	0.00405	CcSEcCtD
Cyclobenzaprine—Vomiting—Vinblastine—head and neck cancer	0.00107	0.00402	CcSEcCtD
Cyclobenzaprine—Headache—Vinblastine—head and neck cancer	0.00105	0.00396	CcSEcCtD
Cyclobenzaprine—Anorexia—Fluorouracil—head and neck cancer	0.00105	0.00396	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Hydroxyurea—head and neck cancer	0.00105	0.00395	CcSEcCtD
Cyclobenzaprine—Hypotension—Fluorouracil—head and neck cancer	0.00103	0.00388	CcSEcCtD
Cyclobenzaprine—Dizziness—Hydroxyurea—head and neck cancer	0.00102	0.00381	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00101	0.00378	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Docetaxel—head and neck cancer	0.001	0.00377	CcSEcCtD
Cyclobenzaprine—Nausea—Vinblastine—head and neck cancer	0.001	0.00376	CcSEcCtD
Cyclobenzaprine—Insomnia—Fluorouracil—head and neck cancer	0.000999	0.00375	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Fluorouracil—head and neck cancer	0.000992	0.00373	CcSEcCtD
Cyclobenzaprine—Alopecia—Docetaxel—head and neck cancer	0.000992	0.00373	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Fluorouracil—head and neck cancer	0.000985	0.0037	CcSEcCtD
Cyclobenzaprine—Somnolence—Fluorouracil—head and neck cancer	0.000982	0.00369	CcSEcCtD
Cyclobenzaprine—Vomiting—Hydroxyurea—head and neck cancer	0.000976	0.00367	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Fluorouracil—head and neck cancer	0.000973	0.00365	CcSEcCtD
Cyclobenzaprine—Rash—Hydroxyurea—head and neck cancer	0.000968	0.00364	CcSEcCtD
Cyclobenzaprine—Dermatitis—Hydroxyurea—head and neck cancer	0.000967	0.00363	CcSEcCtD
Cyclobenzaprine—Headache—Hydroxyurea—head and neck cancer	0.000962	0.00361	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Fluorouracil—head and neck cancer	0.00096	0.00361	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Docetaxel—head and neck cancer	0.000957	0.0036	CcSEcCtD
Cyclobenzaprine—Nausea—Hydroxyurea—head and neck cancer	0.000912	0.00343	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Fluorouracil—head and neck cancer	0.00091	0.00342	CcSEcCtD
Cyclobenzaprine—Urticaria—Fluorouracil—head and neck cancer	0.000878	0.0033	CcSEcCtD
Cyclobenzaprine—Syncope—Docetaxel—head and neck cancer	0.000876	0.00329	CcSEcCtD
Cyclobenzaprine—Leukopenia—Docetaxel—head and neck cancer	0.000875	0.00329	CcSEcCtD
Cyclobenzaprine—Palpitations—Docetaxel—head and neck cancer	0.000863	0.00324	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Docetaxel—head and neck cancer	0.000859	0.00323	CcSEcCtD
Cyclobenzaprine—Convulsion—Docetaxel—head and neck cancer	0.000847	0.00318	CcSEcCtD
Cyclobenzaprine—Hypertension—Docetaxel—head and neck cancer	0.000844	0.00317	CcSEcCtD
Cyclobenzaprine—Chest pain—Docetaxel—head and neck cancer	0.000832	0.00313	CcSEcCtD
Cyclobenzaprine—Myalgia—Docetaxel—head and neck cancer	0.000832	0.00313	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Fluorouracil—head and neck cancer	0.000814	0.00306	CcSEcCtD
Cyclobenzaprine—Dry mouth—Docetaxel—head and neck cancer	0.000814	0.00306	CcSEcCtD
Cyclobenzaprine—Confusional state—Docetaxel—head and neck cancer	0.000804	0.00302	CcSEcCtD
Cyclobenzaprine—Oedema—Docetaxel—head and neck cancer	0.000797	0.003	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Docetaxel—head and neck cancer	0.000797	0.003	CcSEcCtD
Cyclobenzaprine—Shock—Docetaxel—head and neck cancer	0.000785	0.00295	CcSEcCtD
Cyclobenzaprine—Pruritus—Fluorouracil—head and neck cancer	0.000782	0.00294	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Docetaxel—head and neck cancer	0.000781	0.00293	CcSEcCtD
Cyclobenzaprine—Tachycardia—Docetaxel—head and neck cancer	0.000778	0.00292	CcSEcCtD
Cyclobenzaprine—Anorexia—Docetaxel—head and neck cancer	0.00076	0.00286	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Fluorouracil—head and neck cancer	0.000756	0.00284	CcSEcCtD
Cyclobenzaprine—Hypotension—Docetaxel—head and neck cancer	0.000745	0.0028	CcSEcCtD
Cyclobenzaprine—Dizziness—Fluorouracil—head and neck cancer	0.000731	0.00275	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000727	0.00273	CcSEcCtD
Cyclobenzaprine—Insomnia—Docetaxel—head and neck cancer	0.000721	0.00271	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Docetaxel—head and neck cancer	0.000716	0.00269	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Docetaxel—head and neck cancer	0.000711	0.00267	CcSEcCtD
Cyclobenzaprine—Somnolence—Docetaxel—head and neck cancer	0.000709	0.00266	CcSEcCtD
Cyclobenzaprine—Vomiting—Fluorouracil—head and neck cancer	0.000703	0.00264	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Docetaxel—head and neck cancer	0.000702	0.00264	CcSEcCtD
Cyclobenzaprine—Rash—Fluorouracil—head and neck cancer	0.000697	0.00262	CcSEcCtD
Cyclobenzaprine—Dermatitis—Fluorouracil—head and neck cancer	0.000696	0.00262	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Docetaxel—head and neck cancer	0.000693	0.0026	CcSEcCtD
Cyclobenzaprine—Headache—Fluorouracil—head and neck cancer	0.000692	0.0026	CcSEcCtD
Cyclobenzaprine—Fatigue—Docetaxel—head and neck cancer	0.000688	0.00258	CcSEcCtD
Cyclobenzaprine—Constipation—Docetaxel—head and neck cancer	0.000682	0.00256	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Docetaxel—head and neck cancer	0.000657	0.00247	CcSEcCtD
Cyclobenzaprine—Nausea—Fluorouracil—head and neck cancer	0.000656	0.00247	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000652	0.00245	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Docetaxel—head and neck cancer	0.00063	0.00237	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Docetaxel—head and neck cancer	0.000588	0.00221	CcSEcCtD
Cyclobenzaprine—Asthenia—Docetaxel—head and neck cancer	0.000572	0.00215	CcSEcCtD
Cyclobenzaprine—Pruritus—Docetaxel—head and neck cancer	0.000564	0.00212	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Docetaxel—head and neck cancer	0.000546	0.00205	CcSEcCtD
Cyclobenzaprine—Dizziness—Docetaxel—head and neck cancer	0.000527	0.00198	CcSEcCtD
Cyclobenzaprine—Vomiting—Docetaxel—head and neck cancer	0.000507	0.00191	CcSEcCtD
Cyclobenzaprine—Rash—Docetaxel—head and neck cancer	0.000503	0.00189	CcSEcCtD
Cyclobenzaprine—Dermatitis—Docetaxel—head and neck cancer	0.000502	0.00189	CcSEcCtD
Cyclobenzaprine—Headache—Docetaxel—head and neck cancer	0.0005	0.00188	CcSEcCtD
Cyclobenzaprine—Nausea—Docetaxel—head and neck cancer	0.000474	0.00178	CcSEcCtD
